stockrowPetros Pharmaceuticals, Inc. (PTPI) vs Sunshine Biopharma, Inc. (SBFM)
- Petros Pharmaceuticals, Inc. PTPI 0.00 NaN
- Sunshine Biopharma, Inc. SBFM 2.71 −2.87%
Petros Pharmaceuticals, Inc. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Sunshine Biopharma, Inc. is the larger, with a market value of $2.1M against $1.0M — 2.0× the size. Sunshine Biopharma, Inc. grew revenue faster over the last twelve months: −2.74% against −12.2%. Petros Pharmaceuticals, Inc. has the higher net margin (0.00% vs −16.5%) and the higher return on invested capital (0.00% vs −26.7%). Across the 15 metrics below, Petros Pharmaceuticals, Inc. leads on 9 and Sunshine Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | PTPI | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 118.32% | 30.30% | 53.51% |
| Operating margin | 0.00% | (16.65%) | 0.00% |
| Net margin | 0.00% | (16.50%) | (2.45%) |
| Free cash flow margin | 0.00% | (15.66%) | 0.00% |
| Return on equity | (710.28%) | (21.93%) | (0.80%) |
| Return on assets | (334.15%) | (17.78%) | (1.67%) |
| Return on invested capital | 0.00% | (26.67%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack